Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Types of Assays for SARS-CoV-2 Testing: A Review.

Tytuł:
Types of Assays for SARS-CoV-2 Testing: A Review.
Autorzy:
Smithgall MC; Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York City, NY.
Dowlatshahi M; Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York City, NY.
Spitalnik SL; Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York City, NY.
Hod EA; Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York City, NY.
Rai AJ
Źródło:
Laboratory medicine [Lab Med] 2020 Sep 01; Vol. 51 (5), pp. e59-e65.
Typ publikacji:
Journal Article; Review
Język:
English
Imprint Name(s):
Publication: Oct. 2015- : Oxford, England: Oxford University Press
Original Publication: Philadelphia, Lippincott.
MeSH Terms:
Betacoronavirus/*genetics
Coronavirus Infections/*diagnosis
Immunoassay/*methods
Molecular Diagnostic Techniques/*methods
Pneumonia, Viral/*diagnosis
Reverse Transcriptase Polymerase Chain Reaction/*methods
Serologic Tests/*methods
Antibodies, Viral/blood ; Antibodies, Viral/immunology ; Betacoronavirus/immunology ; COVID-19 ; Coronavirus Infections/blood ; Humans ; Immunoassay/standards ; Molecular Diagnostic Techniques/standards ; Pandemics ; Pneumonia, Viral/blood ; Reverse Transcriptase Polymerase Chain Reaction/standards ; SARS-CoV-2 ; Sensitivity and Specificity ; Serologic Tests/standards
References:
J Clin Microbiol. 2016 Dec 28;55(1):226-233. (PMID: 27807150)
J Clin Virol. 2020 Jul;128:104429. (PMID: 32425657)
Nat Med. 2020 Jun;26(6):845-848. (PMID: 32350462)
J Med Virol. 2020 Sep;92(9):1475-1483. (PMID: 32356910)
J Clin Microbiol. 2020 Jul 23;58(8):. (PMID: 32327448)
J Clin Virol. 2020 Jul;128:104428. (PMID: 32434706)
Pneumonia (Nathan). 2017 Feb 25;9:4. (PMID: 28702306)
Lancet Infect Dis. 2020 May;20(5):565-574. (PMID: 32213337)
AIDS. 2018 Sep 24;32(15):2089-2102. (PMID: 30102659)
Lancet. 2020 Feb 15;395(10223):507-513. (PMID: 32007143)
Rev Med Virol. 2020 May;30(3):e2107. (PMID: 32267987)
Clin Infect Dis. 2020 Nov 19;71(16):2027-2034. (PMID: 32221519)
J Clin Microbiol. 2020 Apr 23;58(5):. (PMID: 32102856)
Substance Nomenclature:
0 (Antibodies, Viral)
Entry Date(s):
Date Created: 20200714 Date Completed: 20200907 Latest Revision: 20231112
Update Code:
20240105
PubMed Central ID:
PMC7454768
DOI:
10.1093/labmed/lmaa039
PMID:
32657343
Czasopismo naukowe
Clinical laboratory testing routinely provides actionable results, which help direct patient care in the inpatient and outpatient settings. Since December 2019, a novel coronavirus (SARS-CoV-2) has been causing disease (COVID-19 [coronavirus disease 2019]) in patients, beginning in China and now extending worldwide. In this context of a novel viral pandemic, clinical laboratories have developed multiple novel assays for SARS-CoV-2 diagnosis and for managing patients afflicted with this illness. These include molecular and serologic-based tests, some with point-of-care testing capabilities. Herein, we present an overview of the types of testing available for managing patients with COVID-19, as well as for screening of potential plasma donors who have recovered from COVID-19.
(© American Society for Clinical Pathology 2020. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.)
Comment in: Lab Med. 2020 Sep 1;51(5):443. (PMID: 32869104)

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies